ALK, Torii Pharma sign licensing pact
The tie up licenses Torlii Pharma for the development, marketing and distribution of Mitizax, ALK’s tablet which is indicated for the treatment of house dust allergy. As per
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.